Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$23.35 USD
-0.25 (-1.06%)
Updated Sep 25, 2024 03:59 PM ET
After-Market: $23.34 -0.01 (-0.04%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$39.11 | $56.00 | $28.00 | 65.72% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Bicycle Therapeutics PLC Sponsored ADR comes to $39.11. The forecasts range from a low of $28.00 to a high of $56.00. The average price target represents an increase of 65.72% from the last closing price of $23.60.
Analyst Price Targets (9 )
Broker Rating
Bicycle Therapeutics PLC Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.42 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, eight are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 66.67% and 16.67% of all recommendations. A month ago, Strong Buy made up 75%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 9 | 9 | 10 | 10 |
Buy | 2 | 2 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.46 | 1.42 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | JMP Securities | Reni Benjamin | Strong Buy | Strong Buy |
9/6/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
8/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/7/2024 | B. Riley Securities | Kalpit Patel | Hold | Hold |
8/7/2024 | Cantor Fitzgerald & Co | Li Watsek | Strong Buy | Strong Buy |
8/7/2024 | Needham & Company | Ami Fadia | Moderate Buy | Moderate Buy |
8/7/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Strong Buy | Strong Buy |
8/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/6/2024 | Cowen & Co. | Tara Bancroft | Strong Buy | Strong Buy |
5/2/2024 | SVB Securities | Jonathan W Chang | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.46 |
# of Recs in ABR | 12 |
Average Target Price | $39.11 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.78 |
BCYC FAQs
Bicycle Therapeutics PLC Sponsored ADR (BCYC) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms.
The average price target for Bicycle Therapeutics PLC Sponsored ADR (BCYC) is $39.11. The current on short-term price targets is based on 8 reports.
The forecasts for Bicycle Therapeutics PLC Sponsored ADR (BCYC) range from a low of $28 to a high of $56. The average price target represents a increase of $65.72 from the last closing price of $23.60.
The current UPSIDE for Bicycle Therapeutics PLC Sponsored ADR (BCYC) is 65.72%
Based on short-term price targets offered by nine analysts, the average price target for Bicycle Therapeutics PLC Sponsored ADR comes to $39.11. The forecasts range from a low of $28.00 to a high of $56.00. The average price target represents an increase of 65.72% from the last closing price of $23.60.